Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.

Mollica A, Paglialunga Paradisi M, Torino D, Spisani S, Lucente G.

Amino Acids. 2006 Jun;30(4):453-9. Epub 2006 Mar 20.

PMID:
16547648
2.

Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.

Giordano C, Lucente G, Masi A, Paglialunga Paradisi M, Sansone A, Spisani S.

Amino Acids. 2007 Sep;33(3):477-87. Epub 2006 Oct 6.

PMID:
17021652
3.

Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.

Giordano C, Lucente G, Mollica A, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Gavuzzo E, Mazza F, Spisani S.

J Pept Sci. 2004 Aug;10(8):510-23.

PMID:
15347138
4.

The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.

Cavicchioni G, Breveglieri A, Boggian M, Vertuani G, Reali E, Spisani S.

J Pept Sci. 1996 May-Jun;2(3):135-40.

PMID:
9231322
5.

Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.

Lucente G, Giordano C, Sansone A, Torino D, Spisani S.

Amino Acids. 2009 Jul;37(2):285-95. doi: 10.1007/s00726-008-0145-3. Epub 2008 Jul 18.

PMID:
18636221
6.

Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.

Zecchini GP, Paradisi MP, Torrini I, Nalli M, Lucente G, Spisani S.

Farmaco. 2000 Apr;55(4):308-13.

PMID:
10966163
7.

Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.

Giordano C, Lucente G, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Varani K, Spisani S.

Farmaco. 2003 Nov;58(11):1121-30.

PMID:
14572863
8.

Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.

Pagani Zecchini G, Nalli M, Mollica A, Lucente G, Paglialunga Paradisi M, Spisani S.

J Pept Res. 2002 Jun;59(6):283-91.

PMID:
12010519
9.

Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.

Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Spisani S, Giuliani AL.

Int J Pept Protein Res. 1991 Dec;38(6):495-504.

PMID:
1668096
10.

Fluoro-modified chemotactic peptides: fMLF analogues.

Koksch B, Dahl C, Radics G, Vocks A, Arnold K, Arnhold J, Sieler J, Burger K.

J Pept Sci. 2004 Feb;10(2):67-81.

PMID:
14994985
11.

Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.

Pagani Zecchini G, Paglialunga Paradisi M, Torrini I, Lucente G, Mastropietro G, Paci M, Spisani S.

Arch Pharm (Weinheim). 1996 Dec;329(12):517-23.

PMID:
9038418
12.

Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.

Zecchini GP, Paradisi MP, Torrini I, Spisani S.

Arch Pharm (Weinheim). 1995 Sep;328(9):673-6.

PMID:
7487425
13.

Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.

Pagani Zecchini G, Torrini I, Paglialunga Paradisi M, Lucente G, Spisani S.

Farmaco. 1994 Nov;40(11):739-42.

PMID:
7832975
14.

Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.

Torino D, Mollica A, Pinnen F, Feliciani F, Spisani S, Lucente G.

Bioorg Med Chem. 2009 Jan 1;17(1):251-9. doi: 10.1016/j.bmc.2008.11.010. Epub 2008 Nov 12.

PMID:
19081258
15.

Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.

Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Mastropietro G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.

Biopolymers. 1996 Sep;39(3):327-37.

PMID:
8756513
16.

For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.

Torrini I, Zecchini GP, Paradisi MP, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.

Biopolymers. 1995 Apr;35(4):347-58.

PMID:
7711275
17.

Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.

Ferretti ME, Nalli M, Biondi C, Colamussi ML, Pavan B, Traniello S, Spisani S.

Cell Signal. 2001 Apr;13(4):233-40.

PMID:
11306240
18.

Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.

Pagani Zecchini G, Paglialunga Paradisi M, Torrini I, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Paci M, Sette M, Di Nola A, et al.

Biopolymers. 1993 Mar;33(3):437-51.

PMID:
8461452
19.

Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.

Boggian M, Vertuani G, Cavicchioni G, Pecoraro R, Scatturin A, Spisani S.

Farmaco. 1997 Jun-Jul;52(6-7):439-44.

PMID:
9372595
20.

New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.

Torrini I, Mastropietro G, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Spisani S.

Arch Pharm (Weinheim). 1998 May;331(5):170-6.

PMID:
9691248

Supplemental Content

Support Center